Riskpilot← Back to searchSign inGet full accessPRONOVA BIOPHARMA DANMARK A/S
A/SDissolvedCVR 28291736Juelsmindevej 5Manufacture of oils and fats · NACE 1041Est. 2004— employees
Revenue 2013
DKK 419,1M
EBITDA margin
67.6%
Equity ratio
75.3%
Financial strength
Net profit 2013
DKK -58,1M
| Revenue | DKK 419,1M | — |
| EBITDA | DKK 283,5M | — |
| Net profit | DKK -58,1M | — |
| Total assets | DKK 1,2B | — |
| Equity | DKK 933,7M | — |
| Employees | — | — |
Legal name
PRONOVA BIOPHARMA DANMARK A/S
CVR number
28291736
Legal form
Aktieselskab
NACE code
1041 · Manufacture of oils and fats
Founded
25. november 2004
Share capital
DKK 520.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2013-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør og af to bestyrelsesmedlemmer i forening.
Address
Juelsmindevej 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 |
|---|---|
| Revenue | 419.117 |
| Staff expenses | -76.937 |
| EBITDA | 283.454 |
| Depreciation & amort. | -368.637 |
| EBIT | -85.183 |
| Net financials | 55 |
| Profit before tax | -85.127 |
| Tax | -27.010 |
| Net profit | -58.117 |
| Item | 2013 |
|---|---|
| Total assets | 1.240.264 |
| Equity | 933.700 |
| Long-term debt | 36.837 |
| Short-term debt | 245.023 |
| Total debt | 281.860 |
EBITDA margin
67.6%
This company
15.8%
Market median
+328% vs market
20132013
Equity ratio
75.3%
This company
38.2%
Market median
+97% vs market
20132013
Return on equity
-6.2%
This company
18.4%
Market median
-134% vs market
20132013
Net profit margin
-13.9%
This company
8.1%
Market median
-272% vs market
20132013
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20132013
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20132013
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
CH Management | Management | 2010 – 2014 |
SS Management | Management | 2004 – 2007 |
HU Audit | Audit | 2004 – 2007 |
KO Management | Management | 2008 – 2010 |
TS Management | Management | 2007 – 2008 |
| Name | Role | Member since |
|---|---|---|
| Former (9) | ||
| Board of Directors | 2006 – 2007 | |
| Board of Directors | 2013 – 2014 | |
| Board of Directors | 2004 – 2007 | |
| Chairman | 2013 – 2014 | |
| Chairman | 2007 – 2013 | |
| Board of Directors | 2010 – 2014 | |
| Board of Directors | 2008 – 2009 | |
| Board of Directors | 2004 – 2006 | |
| Board of Directors | 2009 – 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PRONOVA BIOPHARMA DANMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Hjorth Jensen | Management | 0 companies |
| Steen Schierbeck | Management | 0 companies |
| Henrik Ulvsgaard | Audit | 0 companies |
| Kjetil Olsen | Management | 0 companies |
| Tomas Settevik | Management | 0 companies |
| Stine Monefeldt Holm | Board of Directors | 0 companies |
| Charlotte Berg-Svendsen | Board of Directors | 0 companies |
| Britta Madsen | Board of Directors | 0 companies |
| Ralf Fink | Chairman | 0 companies |
| Morten Jurs | Chairman | 0 companies |
| Trygve Christophersen | Board of Directors | 0 companies |
| Per-Oluf Olsen | Board of Directors | 0 companies |
| Svend Carstensen | Board of Directors | 0 companies |
| Synne Hermansen Røine | Board of Directors | 0 companies |